Deltagen Inc. (DGEN)
Deltagen Inc. operates in the Biotechnology industry of the Healthcare sector, headquartered in San Mateo, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $3,859. On trailing twelve-month figures it carries a trailing P/E of 0.04, a net margin of 28.9%. Its beta of 2.49 implies it has historically moved more than the broad market.
Deltagen Inc. provides drug discovery tools and services to the biopharmaceutical industry. The company offers a suite of programs designed to enhance the efficiency of drug discovery, including access to biological models, as well as small-molecule and secreted protein drug targets. It also provides target validation data in the areas of immunology and metabolic diseases. The company was incorporated in 1999 and is headquartered in San Mateo, California.
Deltagen Inc. is most often compared with the following Healthcare names: